Skip to main content

Vodafone Idea share price jumps 10% as board to mull fund raising

 The board will assess capital raising measures such as public issue, preferential allotment, private placement, including a qualified institutions placement, by way of issuing equity shares of other instruments.

Vodafone Idea share price spiked 10 percent at open on September 2 after the company said its board will meet on September 4 to discuss fund raising proposals, as it struggles to keep its business alive in India.

The board will assess capital raising measures such as public issue, preferential allotment, private placement, including a qualified institutions placement, by way of issuing equity shares of other instruments.

In a statement to the BSE, Vodafone Idea said the board will "consider and evaluate any and all proposals for raising of funds in one or more tranches by way of a public issue, preferential allotment, private placement, including a qualified institutions placement or through any other permissible mode and/or combination thereof as may be considered appropriate, by way of issue of equity shares or by way of issue of any instruments or securities".

The company has been under immense pressure related to the AGR dues. It was trading at Rs 9.75, up Rs 0.86, or 9.67 percent. It has touched an intraday high of Rs 9.77 and an intraday low of Rs 9.25.

On September 1, the Supreme Court allowed telecom players a 10-year timeline to pay adjusted gross revenue (AGR) dues. The apex court also asked the companies to make an upfront payment of 10 percent of the outstanding amount.

According to an assessment by the Department of Telecommunications, (DoT), Vodafone Idea owed Rs 58,254 crore. The telecom major owes balance AGR-related dues of around Rs 50,399 crore, Solicitor General Tushar Mehta said on July 20.

The Telecom Regulatory Authority of India (TRAI) has granted Vodafone Idea additional time till September 4 to respond to its showcause notice on priority plan RedX, a source told PTI.

Labels:

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more